AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19229449 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency repetitive transcranial magnetic stimulation (0.5 Hz, 15 min/session, twice a day for 2 weeks)
Number of subjects: 14
Study 19229449 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 14
Study 17373173 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BP) 9% cleanser daily, clindamycin 1% foam daily, doxycycline 100 mg twice daily
Number of subjects: 0
Study 17373173 — intervention group
Group type: COMPARATOR
Intervention: Benzoyl peroxide (BP) 9% cleanser daily, doxycycline 100 mg twice daily without clindamycin 1% foam
Number of subjects: 0
Study 15795602 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 32
Study 15795602 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard of care
Number of subjects: 32
Study 11999456 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program (squeezing a ball, 20 times each hand, three times a day, at least three times a week)
Number of subjects: 16
Study 11999456 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study 11999456 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program
Number of subjects: 16
Study 9592633 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I (rhIGF‐I) therapy (40‐80 micrograms/kg/day)
Number of subjects: 0
Study 9592633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8137669 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 liters of polyethylene glycol with bisacodyl
Number of subjects: 382
Study 8137669 — intervention group
Group type: COMPARATOR
Intervention: 4 liters of polyethylene glycol
Number of subjects: 382
Study 2672819 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 1%
Number of subjects: 32
Study 2672819 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.5%
Number of subjects: 32
Study 2672819 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine (both concentrations)
Number of subjects: 32
Study 2672819 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine
Number of subjects: 32
Study 788907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 2 mg three times daily for 14 days
Number of subjects: 40
Study 788907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 788907 — intervention group
Group type: EXPERIMENTAL
Intervention: Before treatment
Number of subjects: 40
Study 788907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE)
Number of subjects: 40
Study 31645199 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS over the right DLPFC for 20 minutes before the DF task
Number of subjects: 0
Study 31645199 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study 31645199 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS over the right DLPFC
Number of subjects: 0
Study 30531382 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Multimodal Exercise Boot Camp (HIBC)
Number of subjects: 27
Study 30531382 — intervention group
Group type: COMPARATOR
Intervention: Usual Care, Low-Intensity Exercise Program (UC)
Number of subjects: 27
Study 27938898 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood conservation protocol (2009)
Number of subjects: 890
Study 26118138 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences of major discrimination
Number of subjects: 221
Study 26118138 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate counts of everyday and major discrimination
Number of subjects: 221
Study 26118138 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience of discrimination in getting care for physical health
Number of subjects: 221
Study 24013702 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation with propofol, midazolam, and piritramide during AF ablation
Number of subjects: 401
Study 21337214 — intervention group
Group type: EXPERIMENTAL
Intervention: guided negative rumination condition
Number of subjects: 114
Study 21337214 — intervention group
Group type: COMPARATOR
Intervention: distraction condition
Number of subjects: 114
Study 21337214 — intervention group
Group type: EXPERIMENTAL
Intervention: both conditions (guided negative rumination and distraction)
Number of subjects: 114
Study 21337214 — intervention group
Group type: EXPERIMENTAL
Intervention: socially anxious individuals
Number of subjects: 114
Study 20019909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadmium exposure (measured as blood cadmium concentration of 0.21 microg/L)
Number of subjects: 0
Study 20019909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadmium exposure
Number of subjects: 0
Study 17251531 — intervention group
Group type: EXPERIMENTAL
Intervention: Posaconazole
Number of subjects: 602
Study 17251531 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole or Itraconazole
Number of subjects: 602
Study 15509356 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions intervention
Number of subjects: 159
Study 15509356 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention (control) group
Number of subjects: 159
Study 11820754 — intervention group
Group type: EXPERIMENTAL
Intervention: Judging spatial relationships at encoding
Number of subjects: 0
Study 11820754 — intervention group
Group type: EXPERIMENTAL
Intervention: Judging physical and semantic object attributes
Number of subjects: 0
Study 11820754 — intervention group
Group type: EXPERIMENTAL
Intervention: Object identification at encoding
Number of subjects: 0
Study 9726716 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with nebulized 2.5 mg salbutamol plus 0.5 mg ipratropium bromide
Number of subjects: 1064
Study 9726716 — intervention group
Group type: COMPARATOR
Intervention: Nebulized 2.5 mg salbutamol alone
Number of subjects: 1064
Study 8061262 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl anesthesia
Number of subjects: 64
Study 8061262 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-fentanyl anesthesia
Number of subjects: 64
Study 2493044 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 17
Study 2493044 — intervention group
Group type: COMPARATOR
Intervention: Theophylline-terfenadine combination
Number of subjects: 17
Study 779920 — intervention group
Group type: EXPERIMENTAL
Intervention: 113InmCl3
Number of subjects: 2
Study 779920 — intervention group
Group type: COMPARATOR
Intervention: 125I‐labelled human serum albumin
Number of subjects: 2
Study 29698015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 4387
Study 29698015 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE; control condition)
Number of subjects: 4387
Study 26050975 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Support Grant (CSG) receipt duration
Number of subjects: 746
Study 26050975 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV exposure
Number of subjects: 746
Study 26050975 — intervention group
Group type: EXPERIMENTAL
Intervention: Low birth weight
Number of subjects: 746
Study 26050975 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 746
Study 24077690 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic tranexamic acid
Number of subjects: 60
Study 24077690 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion
Number of subjects: 60
Study 24077690 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 22866562 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine interaction
Number of subjects: 33
Study 22866562 — intervention group
Group type: COMPARATOR
Intervention: Viewing a canine movie (control)
Number of subjects: 33
Study 21242603 — intervention group
Group type: EXPERIMENTAL
Intervention: jOG intervention
Number of subjects: 42
Study 17611232 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav (50 mg/kg/day in three doses for 10 days)
Number of subjects: 502
Study 17611232 — intervention group
Group type: COMPARATOR
Intervention: Parenteral ceftriaxone (50 mg/kg/day in a single parenteral dose for three days) followed by oral co-amoxiclav (50 mg/kg/day in three divided doses for seven days)
Number of subjects: 502
Study 17611232 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav
Number of subjects: 502
Study 17611232 — intervention group
Group type: COMPARATOR
Intervention: Parenteral ceftriaxone followed by oral co-amoxiclav
Number of subjects: 502
Study 15627814 — intervention group
Group type: EXPERIMENTAL
Intervention: DRD4 2- or 5-allele polymorphism in men
Number of subjects: 125
Study 15627814 — intervention group
Group type: EXPERIMENTAL
Intervention: DRD4 2- or 5-allele polymorphism in women
Number of subjects: 125
Study 15627814 — intervention group
Group type: EXPERIMENTAL
Intervention: Novelty Seeking (NS) in men
Number of subjects: 125
Study 15627814 — intervention group
Group type: EXPERIMENTAL
Intervention: Novelty Seeking (NS) in women
Number of subjects: 125
Study 12162764 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/epinephrine injectable gel
Number of subjects: 179
Study 12162764 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 179
Study 10480519 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients with DKA
Number of subjects: 131
Study 10480519 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean patients with DKA
Number of subjects: 131
Study 10480519 — intervention group
Group type: COMPARATOR
Intervention: Obese patients with hyperglycemia
Number of subjects: 131
Study 10480519 — intervention group
Group type: EXPERIMENTAL
Intervention: All DKA patients with GAD autoantibodies
Number of subjects: 131
Study 10480519 — intervention group
Group type: COMPARATOR
Intervention: HLA distribution
Number of subjects: 131
Study 8916489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 101
Study 1674853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsapirone, 0.3 mg/kg
Number of subjects: 12
Study 1674853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1674853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsapirone
Number of subjects: 12
Study 6758747 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Heparin
Number of subjects: 234
Study 6758747 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Heparin
Number of subjects: 234
Study 6758747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 31627905 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy
Number of subjects: 0
Study 31163755 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSMO method
Number of subjects: 0
Study 31163755 — intervention group
Group type: COMPARATOR
Intervention: Assigned PA aware SMO
Number of subjects: 0
Study 28805045 — intervention group
Group type: EXPERIMENTAL
Intervention: IV golimumab at 2 mg/kg
Number of subjects: 480
Study 28805045 — intervention group
Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 480
Study 27637858 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 241
Study 27637858 — intervention group
Group type: COMPARATOR
Intervention: Standard wedge radiotherapy
Number of subjects: 241
Study 24646165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with single contact
Number of subjects: 4676
Study 24646165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with dual contact
Number of subjects: 4676
Study 24646165 — intervention group
Group type: COMPARATOR
Intervention: Control with single contact
Number of subjects: 4676
Study 24646165 — intervention group
Group type: COMPARATOR
Intervention: Control with dual contact
Number of subjects: 4676
Study 24646165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups (single and dual contact)
Number of subjects: 4676
Study 24646165 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 4676
Study 23286405 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 275
Study 23286405 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 275
Study 23286405 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 275
Study 19630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 77
Study 19630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy
Number of subjects: 77
Study 19630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive factor estimated cost
Number of subjects: 77
Study 19630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive factor estimated cost and treatment
Number of subjects: 77
Study 19630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment use of anxiolytics
Number of subjects: 77
Study 17645261 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined TCM and western medicine
Number of subjects: 90
Study 17645261 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM
Number of subjects: 90
Study 17645261 — intervention group
Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 90
Study 16286871 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of whey and caseinate proteins (PROT)
Number of subjects: 10
Study 16286871 — intervention group
Group type: COMPARATOR
Intervention: Noncaloric placebo (P)
Number of subjects: 10
Study 12077712 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-DRB1*0301-DQB1*0201 haplotype
Number of subjects: 73
Study 9862605 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0
Study 9862605 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 9862605 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover to alternative medication
Number of subjects: 0
Study 8548054 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (100 mg)
Number of subjects: 14
Study 8548054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2296932 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg daily oral folic acid supplement (F group)
Number of subjects: 245
Study 2296932 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P group)
Number of subjects: 245
Study 6968153 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant or antiplatelet therapy
Number of subjects: 0
Study 6968153 — intervention group
Group type: COMPARATOR
Intervention: Control (no antithrombotic therapy)
Number of subjects: 0
Study 31055526 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal body mass with expressed endogenous intoxication syndrome
Number of subjects: 58
Study 31055526 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal body mass with minimum degree of endogenous intoxication
Number of subjects: 58
Study 31055526 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased level of blood medium-weight molecules (MWM254)
Number of subjects: 58
Study 31055526 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hypoleptinemia with severe endogenous intoxication
Number of subjects: 58
Study 31055526 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of leptin level
Number of subjects: 58
Study 27617694 — intervention group
Group type: EXPERIMENTAL
Intervention: SwimOnly
Number of subjects: 13
Study 27617694 — intervention group
Group type: EXPERIMENTAL
Intervention: SwimDry
Number of subjects: 13
Study 27617694 — intervention group
Group type: COMPARATOR
Intervention: NoEx
Number of subjects: 13
Study 25879452 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated hip strengthening
Number of subjects: 150
Study 25879452 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps-based training
Number of subjects: 150
Study 25879452 — intervention group
Group type: COMPARATOR
Intervention: Free physical activity (Control)
Number of subjects: 150
Study 24025260 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week intensive exercise program for the whole body (including locomotor training, trunk exercises, and functional electrical stimulation-assisted cycling)
Number of subjects: 188
Study 24025260 — intervention group
Group type: COMPARATOR
Intervention: 12-week intensive upper body exercise program
Number of subjects: 188
Study 21412146 — intervention group
Group type: EXPERIMENTAL
Intervention: Open insertion technique performed by surgeons
Number of subjects: 110
Study 21412146 — intervention group
Group type: COMPARATOR
Intervention: Puncture of the subclavian vein under fluoroscopic guidance by radiologists
Number of subjects: 110
Study 19626360 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen nasogastric tube (NGT)
Number of subjects: 100
Study 19626360 — intervention group
Group type: COMPARATOR
Intervention: Standard nasogastric tube (control)
Number of subjects: 100
Study 19626360 — intervention group
Group type: COMPARATOR
Intervention: Both groups (frozen and control)
Number of subjects: 100
Study 19160425 — intervention group
Group type: EXPERIMENTAL
Intervention: Video rigid laryngoscopy (VRL)
Number of subjects: 43
Study 19160425 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mirror examination (LME)
Number of subjects: 43
Study 16365887 — intervention group
Group type: EXPERIMENTAL
Intervention: ThermaCool device (one treatment)
Number of subjects: 10
Study 16365887 — intervention group
Group type: EXPERIMENTAL
Intervention: ThermaCool device (two treatments)
Number of subjects: 10
Study 16365887 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study 16365887 — intervention group
Group type: EXPERIMENTAL
Intervention: ThermaCool device (one and two treatments)
Number of subjects: 10
Study 12068188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoid J-pouch
Number of subjects: 92
Study 12068188 — intervention group
Group type: EXPERIMENTAL
Intervention: Descending J-pouch
Number of subjects: 92
Study 9678146 — intervention group
Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 0
Study 8820528 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 0
Study 8820528 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant treatment
Number of subjects: 0
Study 2242492 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic salmon calcitonin (sCT) 100 MRC U injected i.m. every other day for 12 months
Number of subjects: 0
Study 2242492 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection for the first 6 months, followed by sCT 100 MRC U injected i.m. every other day for the next 6 months
Number of subjects: 0
Study 358766 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose of lidocaine (bolus dose 50 mg followed by infusion 3 mg/min)
Number of subjects: 31
Study 358766 — intervention group
Group type: EXPERIMENTAL
Intervention: QX-572 (600 mg N,N‐bis dimethylammonium chloride) as an i.v. infusion during 30 min or 60 min
Number of subjects: 31
Study 358766 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard lidocaine therapy)
Number of subjects: 31
Study 12474611 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0
Study 31332914 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counselling (three sessions at 1, 4, and 8 weeks; three telephone follow-ups over 13 weeks)
Number of subjects: 76
Study 31332914 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counselling
Number of subjects: 76
Study 31332914 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study 30015059 — intervention group
Group type: EXPERIMENTAL
Intervention: General laryngeal mask airway (LMA) anesthesia with lumbar plexus-sciatic nerve block (LPSB)
Number of subjects: 63
Study 30015059 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with endotracheal intubation (ET)
Number of subjects: 63
Study 26140543 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 56
Study 26140543 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (Cu-IUD)
Number of subjects: 56
Study 24802206 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified Conventional Treatment (ICT)
Number of subjects: 72
Study 24802206 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 72
Study 22499718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng (G)
Number of subjects: 52
Study 22499718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng + Exercise (G+Ex)
Number of subjects: 52
Study 22499718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 52
Study 19776738 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 98
Study 19230172 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril 10 mg
Number of subjects: 18
Study 19230172 — intervention group
Group type: COMPARATOR
Intervention: cilazapril 5 mg
Number of subjects: 18
Study 15981759 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma clinical pathway implementation
Number of subjects: 270
Study 15981759 — intervention group
Group type: COMPARATOR
Intervention: Usual asthma medical care management (Control)
Number of subjects: 270
Study 15981759 — intervention group
Group type: COMPARATOR
Intervention: General practitioners not participating in the trial
Number of subjects: 270
Study 12114383 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine bronchial provocation
Number of subjects: 22
Study 12114383 — intervention group
Group type: COMPARATOR
Intervention: Eucapnic hyperventilation of dry air
Number of subjects: 22
Study 9931211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen via face mask at 12 l/min (group C)
Number of subjects: 22
Study 9931211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen via nasal prongs at 5 l/min (group B)
Number of subjects: 22
Study 9931211 — intervention group
Group type: COMPARATOR
Intervention: Room air (group A)
Number of subjects: 22
Study 7844680 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral L-carnitine supplementation (50 mumol/kg per day)
Number of subjects: 43
Study 7844680 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral L-carnitine supplementation
Number of subjects: 43